H W Sheppard

Author PubWeight™ 102.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999 18.82
2 HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health 1994 5.18
3 Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 1994 4.35
4 The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997 3.36
5 Viral burden and HIV disease. Nature 1993 3.18
6 The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med 1997 3.05
7 Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci U S A 1991 2.85
8 Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J Virol 1997 2.72
9 Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 2001 2.05
10 A unified hypothesis for three cardinal features of HIV immunology. J Acquir Immune Defic Syndr 1991 2.03
11 Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. J Infect Dis 1991 1.77
12 Allelic forms of rat kappa chain genes: evidence for strong selection at the level of nucleotide sequence. Proc Natl Acad Sci U S A 1981 1.70
13 Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection. J Infect Dis 2000 1.66
14 Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus. J Acquir Immune Defic Syndr 1994 1.57
15 Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis 2000 1.54
16 Dissociation of immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000 1.49
17 Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection. J Acquir Immune Defic Syndr 2001 1.48
18 Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J Virol 1995 1.48
19 AIDS-associated Kaposi's sarcoma. "Duesberg phenomenon'. Science 1995 1.39
20 AIDS as immune system activation: a model for pathogenesis. Clin Exp Immunol 1988 1.39
21 Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA 1993 1.38
22 In vitro studies of the rabbit immune system. IV. Differential mitogen responses of isolated T and B cells. Cell Immunol 1976 1.31
23 Transmission of genetically diverse strains of HIV-1 in Pune, India. Indian J Med Res 1998 1.26
24 Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993 1.22
25 Application of a rapid microplaque assay for determination of human immunodeficiency virus neutralizing antibody titers. J Clin Microbiol 1990 1.10
26 Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Syndr 1994 1.10
27 AIDS as immune system activation. II. The panergic imnesia hypothesis. J Acquir Immune Defic Syndr 1990 1.09
28 Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression. J Virol 1995 1.09
29 Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1996 1.08
30 In vitro studies of the rabbit immune system. V. Suppressor T cells activated by concanavalin A block the proliferation, not the induction of antierythrocyte plaque-forming cells. J Exp Med 1976 1.05
31 Recognition of Leishmania donovani antigens by murine T lymphocyte lines and clones. Species cross-reactivity, functional correlates of cell-mediated immunity, and antigen characterization. J Immunol 1983 1.04
32 Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection. J Infect Dis 1998 1.04
33 Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: a worst-case dynamic analysis. J Acquir Immune Defic Syndr Hum Retrovirol 1998 1.02
34 Cloning of Leishmania donovani genes encoding antigens recognized during human visceral leishmaniasis. Mol Biochem Parasitol 1986 1.02
35 Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res Hum Retroviruses 1998 1.01
36 Rabbit blood lymphocytes may be T cells with surface immunoglobulins. Science 1973 1.00
37 In vitro studies of the rabbit immune system: II. Functional characterization of rabbit T and B populations separated by adherence to nylon wool or lysis with anti-thymocyte serum and complement. Cell Immunol 1976 0.98
38 Effect of new AIDS case definition on numbers of cases among homosexual and bisexual men in San Francisco. JAMA 1991 0.96
39 Rat kappa-chain J-segment genes: two recent gene duplications separate rat and mouse. Cell 1982 0.96
40 CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet 1997 0.92
41 Studies on rabbit lymphocytes in vitro. XX. Demonstration of cells reactive to more than one mitogen by mixed sequential stimulation. Exp Cell Res 1975 0.91
42 Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. Projeto Praço Onze Study Group. J Acquir Immune Defic Syndr 2000 0.90
43 Mixed lymphocyte reactions in the rabbit using peripheral blood cells: the effects of cell preparation and skin grafting. J Immunol Methods 1977 0.89
44 Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection. AIDS Res Hum Retroviruses 1991 0.89
45 Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals. Clin Immunol Immunopathol 1997 0.86
46 The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health Study. Ann Epidemiol 1996 0.86
47 CXCR4 polymorphisms and HIV-1 pathogenesis. J Acquir Immune Defic Syndr Hum Retrovirol 1998 0.85
48 Effects of alpha-fetoprotein on murine immune responses. II. Studies on rats. J Immunol 1977 0.85
49 Effects of alpha-fetoprotein on murine immune responses. I. Studies on mice. J Immunol 1977 0.84
50 Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates. Vaccine 2001 0.82
51 Alloimmunization to prevent AIDS? Science 1994 0.81
52 HIV results in the frame. Paradox remains. Nature 1995 0.81
53 AIDS as immune system activation. Key questions that remain. Adv Exp Med Biol 1995 0.79
54 Studies on rabbit lymphocytes in vitro. XVII. Kinetics of reversible concanavalin A stimulation and restimulation of blast transformation after blocking with alpha-methyl-D-mannopyranoside. Exp Cell Res 1975 0.79
55 Does drug use cause AIDS? Nature 1993 0.78
56 CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression. J Infect Dis 2000 0.78
57 Lack of detection of human immunodeficiency virus in persistently seronegative homosexual men with high or medium risks for infection. J Infect Dis 1991 0.78
58 Complex allotypes of rat kappa chains are encoded by structural alleles. Nature 1981 0.77
59 Aetiology of AIDS. Lancet 1993 0.76
60 The trouble with T cells. Lancet 1990 0.75
61 Median incubation time for human immunodeficiency virus (HIV) Ann Intern Med 1990 0.75
62 AIDS and programmed cell death. Immunol Today 1991 0.75
63 Immunotherapy for HIV. Lancet 1997 0.75
64 Limitations of plasma human immunodeficiency virus RNA testing. Clin Infect Dis 2000 0.75
65 Effect of anti-alpha1-fetoprotein on alpha1-fetoprotein-producing rat tumors in vivo and in vitro. Cancer Res 1976 0.75
66 Studies on rabbit lymphocytes in vitro. 18. Kinetics of reversible Con A stimulation and restimulation of blast transformation after blocking with anti-Con A. Exp Cell Res 1974 0.75
67 Response. Science 1995 0.75
68 Viral burden in HIV disease. J Acquir Immune Defic Syndr 1991 0.75